Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer
Condition: Breast Cancer Interventions: Drug: Pembrolizumab; Drug: Paclitaxel Sponsors: Queen Mary University of London; Merck Sharp & Dohme Corp.; European Institute of Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials